101 related articles for article (PubMed ID: 20230874)
1. Transcription factor ZBP-89 in cancer growth and apoptosis.
Zhang CZ; Chen GG; Lai PB
Biochim Biophys Acta; 2010 Aug; 1806(1):36-41. PubMed ID: 20230874
[TBL] [Abstract][Full Text] [Related]
2. ZBP-89 mediates butyrate regulation of gene expression.
Merchant JL; Bai L; Okada M
J Nutr; 2003 Jul; 133(7 Suppl):2456S-2460S. PubMed ID: 12840224
[TBL] [Abstract][Full Text] [Related]
3. P53 mutants suppress ZBP-89 function.
Okada M; Tessier A; Bai L; Merchant JL
Anticancer Res; 2006; 26(3A):2023-8. PubMed ID: 16827139
[TBL] [Abstract][Full Text] [Related]
4. ZBP-89 promotes growth arrest through stabilization of p53.
Bai L; Merchant JL
Mol Cell Biol; 2001 Jul; 21(14):4670-83. PubMed ID: 11416144
[TBL] [Abstract][Full Text] [Related]
5. Regulation of epithelial cell growth by ZBP-89: potential relevance in pancreatic cancer.
Bai L; Logsdon C; Merchant JL
Int J Gastrointest Cancer; 2002; 31(1-3):79-88. PubMed ID: 12622418
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protection.
Bai L; Kao JY; Law DJ; Merchant JL
Gastroenterology; 2006 Sep; 131(3):841-52. PubMed ID: 16952553
[TBL] [Abstract][Full Text] [Related]
7. Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma.
Zhang CZ; Chen GG; Merchant JL; Lai PB
Cell Cycle; 2012 Jan; 11(2):322-34. PubMed ID: 22214764
[TBL] [Abstract][Full Text] [Related]
8. Targeting ZBP-89 for the treatment of hepatocellular carcinoma.
Wang N; Wang S; Yang SL; Liu LP; Li MY; Lai PBS; Chen GG
Expert Opin Ther Targets; 2018 Oct; 22(10):817-822. PubMed ID: 30142986
[TBL] [Abstract][Full Text] [Related]
9. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
Wu Y; Zhang X; Salmon M; Zehner ZE
Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
[TBL] [Abstract][Full Text] [Related]
10. ZBP-99 defines a conserved family of transcription factors and regulates ornithine decarboxylase gene expression.
Law DJ; Du M; Law GL; Merchant JL
Biochem Biophys Res Commun; 1999 Aug; 262(1):113-20. PubMed ID: 10448078
[TBL] [Abstract][Full Text] [Related]
11. Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89.
Wu Y; Diab I; Zhang X; Izmailova ES; Zehner ZE
Oncogene; 2004 Jan; 23(1):168-78. PubMed ID: 14712222
[TBL] [Abstract][Full Text] [Related]
12. Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89.
Chen GG; Merchant JL; Lai PB; Ho RL; Hu X; Okada M; Huang SF; Chui AK; Law DJ; Li YG; Lau WY; Li AK
Am J Pathol; 2003 Jun; 162(6):1823-9. PubMed ID: 12759240
[TBL] [Abstract][Full Text] [Related]
13. ZBP-89-induced apoptosis is p53-independent and requires JNK.
Bai L; Yoon SO; King PD; Merchant JL
Cell Death Differ; 2004 Jun; 11(6):663-73. PubMed ID: 14963412
[TBL] [Abstract][Full Text] [Related]
14. ZBP-89, a Krüppel-type zinc finger protein, inhibits cell proliferation.
Remington MC; Tarlé SA; Simon B; Merchant JL
Biochem Biophys Res Commun; 1997 Aug; 237(2):230-4. PubMed ID: 9268691
[TBL] [Abstract][Full Text] [Related]
15. Promoter cloning and characterization of the human programmed cell death protein 4 (pdcd4) gene: evidence for ZBP-89 and Sp-binding motifs as essential Pdcd4 regulators.
Leupold JH; Asangani IA; Mudduluru G; Allgayer H
Biosci Rep; 2012 Jun; 32(3):281-97. PubMed ID: 22111549
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of growth hormone receptor gene expression by saturated fatty acids: role of Kruppel-like zinc finger factor, ZBP-89.
Thimmarayappa J; Sun J; Schultz LE; Dejkhamron P; Lu C; Giallongo A; Merchant JL; Menon RK
Mol Endocrinol; 2006 Nov; 20(11):2747-60. PubMed ID: 16825291
[TBL] [Abstract][Full Text] [Related]
17. topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.
Lin L; Ozaki T; Takada Y; Kageyama H; Nakamura Y; Hata A; Zhang JH; Simonds WF; Nakagawara A; Koseki H
Oncogene; 2005 May; 24(21):3385-96. PubMed ID: 15735665
[TBL] [Abstract][Full Text] [Related]
18. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
19. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
Salnikow K; Costa M; Figg WD; Blagosklonny MV
Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
[TBL] [Abstract][Full Text] [Related]
20. p53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction.
Moll UM; Marchenko N; Zhang XK
Oncogene; 2006 Aug; 25(34):4725-43. PubMed ID: 16892086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
